GAM
BNTX icon

Grandview Asset Management’s BioNTech BNTX Stock Holding History

Grandview Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-750
Closed -$82K – 150
2021
Q1 		$82K Buy
+750
New +$79.6K 0.04% 172

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Grandview Asset Management's BNTX Position: Q2 2021 in Review

Grandview Asset Management sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 750 shares — an estimated $82K sold.

Grandview Asset Management first reported a position in BNTX in Q1 2021 and held it in 1 quarter. The position peaked at $82K in Q1 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

  • Grandview Asset Management reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
  • Grandview Asset Management sold 750 BioNTech shares in Q2 2021, an estimated $82K.
  • Grandview Asset Management first reported a position in BioNTech in Q1 2021 and held it in 1 quarter.
  • Grandview Asset Management's BioNTech position peaked at $82K in Q1 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on Grandview Asset Management's 13F filing for Q2 2021, filed 21 Jul 2021.